An overview of current and emerging devices for percutaneous left atrial appendage closure
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Trends in Cardiovascular Medicine |
Vol/bind | 29 |
Udgave nummer | 4 |
Sider (fra-til) | 228-236 |
ISSN | 1050-1738 |
DOI | |
Status | Udgivet - 2019 |
Bibliografisk note
Copyright © 2018 Elsevier Inc. All rights reserved.
ID: 233727736